Tyrosine kinase inhibitor AG1024 exerts antileukaemic effects on STI571-resistant Bcr-Abl expressing cells and decreases AKT phosphorylation
Deutsch, E, Maggiorella, L, Wen, B, Bonnet, M L, Khanfir, K, Frascogna, V, Turhan, A G, Bourhis, JLanguage:
english
Pages:
1
Journal:
British Journal of Cancer
DOI:
10.1038/sj.bjc.6602190
Date:
October, 2004
File:
PDF, 139 KB
english, 2004